Skip to main content
Eligibility
for people ages 18 years to 59 years
Location
at San Francisco, California and other locations
Dates
study started
estimated completion:
Principal Investigator

Description

Summary

This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.

Official Title

A Randomized Comparison of NeoCart to Microfracture for the Repair of Articular Cartilage Injuries in the Knee

Keywords

Articular Cartilage Defects in the Knee Joint

Eligibility

You can join if…

Open to people ages 18 years to 59 years

  • greater than 18 years old
  • symptomatic articular cartilage lesion of the femur and/or trochlea

You CAN'T join if...

  • prior surgical intervention other than debridement
  • arthritis
  • clinically significant or symptomatic vascular or neurologic disorder of the lower extremities

Locations

  • Grossmont Orthopedic Medical Group accepting new patients
    La Mesa, California, 91942, USA
  • Orthopaedic Specialty Institute/Newport Orthopedic Institute (OSI/NOI) accepting new patients
    Orange, California, 92868, USA
  • Advanced Orthopedic Surgery Center accepting new patients
    Temecula, California, USA
  • Southern California Orthopedic Research and Education accepting new patients
    Van Nuys, California, 91405, USA

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Histogenics Corporation
Links
NeoCart Phase 3 Study WebSite
ID
NCT01066702
Phase
Phase 3
Lead Scientist
C. Benjamin Ma
Study Type
Interventional
Last Updated
February 2017
I'm interested in this study!